NCT07542782 Pancreatic Resection in Fit Octogenarians With Nonmetastatic Pancreatic Cancer Status COMPLETED Phase N/A
NCT07542041 Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens Status RECRUITING Phase NA
NCT07542002 Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors:A Prospective Exploratory Study Status RECRUITING Phase PHASE2
NCT07536841 Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis Status NOT_YET_RECRUITING Phase N/A
NCT07529808 Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07513116 Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening Status NOT_YET_RECRUITING Phase NA
NCT07504263 Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07491445 Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma Status RECRUITING Phase PHASE3
NCT07488884 Open-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept, Sotevtamab, and Zabadinostat in Combination With Gemcitabine and Nab-Paclitaxel for Participants With Borderline Resectable or Locally Advanced Pancreatic Cancer Status NOT_YET_RECRUITING Phase PHASE1
NCT07470268 Impact of Hypertrophy-oriented Resistance Training on Muscle Mass and Quality of Life in Patients With Unresectable Pancreatic Cancer Status NOT_YET_RECRUITING Phase NA
NCT07448376 EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases Status NOT_YET_RECRUITING Phase N/A
NCT07444541 ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07429487 Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer Status NOT_YET_RECRUITING Phase NA
NCT07418164 Endoscopic Management of Biliopancreatic Disease in the Lombardy Pancreas Units Status NOT_YET_RECRUITING Phase N/A
NCT07415525 IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07412301 The Effect of Celiac Axis Stenosis on Morbidity After Pancreatoduodenectomy - A Prospective Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07409272 A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer Status RECRUITING Phase PHASE3